Loading institutional data...
Loading institutional data...
Held by 535 of 2,417 reporting institutions (98th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 30% of free cash flow, leaving room to grow it and fund buybacks. Last year: $789.8M dividends + $0 buybacks = $789.8M returned on $2.65B FCF.
6 consecutive years of dividend increases · -1%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 17%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.57B 100.0% | $23.10B 100.0% | $23.05B 100.0% | $22.15B 100.0% | $19.94B 100.0% | $18.36B 100.0% | $17.90B 100.0% | $17.53B 100.0% | $14.98B 100.0% | $11.86B 100.0% |
| Cost of Revenue | $12.06B 51.2% | $11.90B 51.5% | $12.29B 53.3% | $12.82B 57.9% | $11.40B 57.2% | $9.68B 52.7% | $9.86B 55.1% | $10.12B 57.7% | $8.26B 55.2% | $5.93B 50.1% |
| Gross Profit | $11.52B 48.8% | $11.20B 48.5% | $10.76B 46.7% | $9.33B 42.1% | $8.54B 42.8% | $8.68B 47.3% | $8.04B 44.9% | $7.42B 42.3% | $6.72B 44.8% | $5.92B 49.9% |
| Research & Development | — | — | — | — | — | — | — | $51.9M 0.3% | $58.5M 0.4% | $58.0M 0.5% |
| Selling, General & Admin | $7.70B 32.6% | $7.42B 32.1% | $7.07B 30.6% | $6.33B 28.6% | $5.88B 29.5% | $5.48B 29.8% | $5.27B 29.5% | $5.03B 28.7% | $4.80B 32.0% | $4.14B 34.9% |
| Operating Income | — | — | $4.16B 18.1% | $3.40B 15.3% | $3.08B 15.5% | $3.37B 18.4% | $2.81B 15.7% | $2.61B 14.9% | $2.24B 14.9% | $2.16B 18.3% |
| Interest Expense | $465.0M 2.0% | $415.7M 1.8% | $417.5M 1.8% | $390.8M 1.8% | $334.7M 1.7% | $340.4M 1.9% | $349.3M 2.0% | $366.7M 2.1% | $263.5M 1.8% | $154.1M 1.3% |
| Interest & Investment Income | — | — | $25.2M 0.1% | $8.0M 0.0% | $4.9M 0.0% | $3.6M 0.0% | — | — | — | — |
| Other Income (Expense), net | -$20.9M -0.1% | $44.7M 0.2% | -$65.5M -0.3% | -$47.0M -0.2% | $19.5M 0.1% | -$5.3M -0.0% | -$16.7M -0.1% | -$20.1M -0.1% | $32.7M 0.2% | $11.8M 0.1% |
| Pretax Income | $3.34B 14.2% | $3.45B 14.9% | $3.11B 13.5% | $2.57B 11.6% | $2.25B 11.3% | $2.52B 13.7% | $1.98B 11.1% | $1.36B 7.8% | $1.47B 9.8% | $1.60B 13.5% |
| Income Tax Expense | $769.7M 3.3% | $770.4M 3.3% | $721.1M 3.1% | $553.0M 2.5% | $384.2M 1.9% | $488.8M 2.7% | $440.5M 2.5% | $251.0M 1.4% | -$300.2M -2.0% | $462.5M 3.9% |
| Net Income | $2.57B 10.9% | $2.68B 11.6% | $2.39B 10.4% | $2.02B 9.1% | $1.86B 9.3% | $2.03B 11.1% | $1.54B 8.6% | $1.11B 6.3% | $1.73B 11.5% | $1.13B 9.6% |
| Per Share | ||||||||||
| EPS (Basic) | $10.37 | $10.68 | $9.35 | $7.83 | $7.10 | $7.48 | $5.60 | $11.92 | $18.60 | $12.33 |
| EPS (Diluted) | $10.26 | $10.55 | $9.25 | $7.72 | $6.98 | $7.36 | $5.50 | $11.67 | $18.20 | $11.99 |
| Weighted Avg Shares (Basic) | 247.6M | 251.0M | 255.4M | 258.0M | 262.5M | 271.3M | 275.4M | 93.0M | 92.9M | 91.8M |
| Weighted Avg Shares (Diluted) | 250.4M | 254.1M | 258.3M | 261.8M | 267.1M | 275.8M | 280.3M | 95.0M | 94.9M | 94.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $332.61 today, the market must believe free cash flow compounds 12.1%/yr for a decade (off $2.46B on the 3-yr avg basis).
On the basis ($2.33B) the requirement is 12.8%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 12.1% is more optimistic than its 9-yr track record.
Default is 8.3% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.24B shares (market data) · net debt $10.31B
mean 19.1% · volatility σ 48% · implied rate exceeded in 5/9 yrs
Central path = implied 12.1%/yr growth; shaded band = ±1σ (48%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $207.2M is below the $350.1M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.4% on $10.52B of debt.
Cash of $207.2M is below short-term debt of $1.20B — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Ranked against 6 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HD | $328.2B | 23.1× | 15.4× | 2.0× | 3.2% | 33.3% | 8.6% | 110% | 22.8% | 2.0× | 1,478 |
| LOW | $116.2B | 17.5× | 12.6× | 1.4× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.1× | 899 |
| SHW | $79.7B | 32.2× | 24.4× | 3.4× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | 2.8× | 535 |
| FAST | $60.3B | 48.2× | 32.8× | 7.3× | 8.7% | 45.0% | 15.3% | 31.9% | 30.9% | -0.1× | 462 |
| TSCO | $17.5B | 16.3× | 9.7× | 1.1× | 4.3% | 36.4% | 7.1% | 42.5% | 25.2% | 0.8× | 301 |
| BLDR | $6.8B | 16.2× | 8.0× | 0.5× | -7.4% | 30.4% | 2.9% | 10.0% | 4.9% | 3.1× | 119 |
| FND | $5.4B | 26.2× | 10.9× | 1.1× | 5.1% | 43.6% | 4.5% | 8.7% | 8.0% | 0.4× | 88 |
Peers = companies sharing SHW's sector (Retail-Building Materials, Hardware, Garden Supply) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 79th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 56% against ROIC 17% — 39% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 59.4% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 57.7 | 55.1 | 52.7 | 57.2 | 57.9 | 53.3 | 51.5 | 51.2 |
| Gross Profit | 42.3 | 44.9 | 47.3 | 42.8 | 42.1 | 46.7 | 48.5 | 48.8 |
| R&D | 0.3 | — | — | — | — | — | — | — |
| SG&A | 28.7 | 29.5 | 29.8 | 29.5 | 28.6 | 30.6 | 32.1 | 32.6 |
| Operating Income | 14.9 | 15.7 | 18.4 | 15.5 | 15.3 | 18.1 | — | — |
| Income Tax | 1.4 | 2.5 | 2.7 | 1.9 | 2.5 | 3.1 | 3.3 | 3.3 |
| Net Income | 6.3 | 8.6 | 11.1 | 9.3 | 9.1 | 10.4 | 11.6 | 10.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SHW: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Earns 6.75pts above its cost of capital, but margins are compressing.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 15.3% | 8.3% (today's — no rate published for this year) | 7.0pts |
| FY2020 | 19.0% | 8.3% (today's — no rate published for this year) | 10.6pts |
| FY2021 | 17.4% | 5.8% | 11.6pts |
| FY2022 | 16.8% | 8.2% | 8.6pts |
| FY2023 | 22.3% | 8.4% | 13.8pts |
| FY2024 | 17.4% | 9.4% | 8.0pts |
| FY2025 | 14.9% | 7.7% | 7.2pts |
| Now | 17.0% | 8.3% | 8.6pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 49.9% | 18.3% | 9.6% |
| FY2017 | 44.8% | 14.9% | 11.5% |
| FY2018 | 42.3% | 14.9% | 6.3% |
| FY2019 | 44.9% | 15.7% | 8.6% |
| FY2020 | 47.3% | 18.4% | 11.1% |
| FY2021 | 42.8% | 15.5% | 9.3% |
| FY2022 | 42.1% | 15.3% | 9.1% |
| FY2023 | 46.7% | 18.1% | 10.4% |
| FY2024 | 48.5% | 14.8% | 11.6% |
| FY2025 | 48.8% | 14.2% | 10.9% |
Leverage and buybacks account for 39 points of the 56% return on equity in FY2025. The business earns 17% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$8.0B of goodwill — 47% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
ROIC ex-goodwill is 28.33% against 15.09% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 0.91x of reported profit into free cash flow over 5 years, with accruals negative.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Covers interest 5.9x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 8.48x |
| 5% | 8.05x |
| 10% | 7.63x |
| 15% | 7.21x |
| 20% | 6.78x |
| 25% | 6.36x |
| 30% | 5.93x |
| 35% | 5.51x |
| 40% | 5.09x |
| 45% | 4.66x |
| 50% | 4.24x |
| 55% | 3.82x |
| 60% | 3.39x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Net debt is 3.4x EBITDA, so coverage today depends on earnings holding up rather than on the balance sheet.
At $330.10, free cash flow must compound 12.37%/yr for 10 years. It has done 4.89%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 55.8% | 12.4% |
| FY2021 | −39.7% | 12.4% |
| FY2022 | −31.9% | 12.4% |
| FY2023 | 106.5% | 12.4% |
| FY2024 | −20.9% | 12.4% |
| FY2025 | 27.4% | 12.4% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 3 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $2.57B | $2.57B |
| Share-based comp | $124M | $2.69B |
| Other non-cash & working capital | $760M | $3.45B |
| Operating cash flow | $3.45B | $3.45B |
| Capex | −$798M | $2.65B |
| Free cash flow | $2.65B | $2.65B |
| FCF after SBC | $2.53B | $2.53B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 2.6% | -0.5% | -3.1 points |
| FY2021 | 8.6% | 13.2% | 4.6 points |
| FY2022 | 11.1% | 9.0% | -2.1 points |
| FY2023 | 4.1% | -3.7% | -7.8 points |
| FY2024 | 0.2% | -3.2% | -3.4 points |
| FY2025 | 2.1% | 16.9% | 14.8 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 42.6 days | 69.9 days | 69.4 days | 43.1 days |
| FY2020 | 41.3 days | 68 days | 79.9 days | 29.5 days |
| FY2021 | 43.1 days | 61.7 days | 76.9 days | 27.8 days |
| FY2022 | 42.2 days | 74.8 days | 69.3 days | 47.7 days |
| FY2023 | 39.1 days | 69.2 days | 68.7 days | 39.5 days |
| FY2024 | 37.7 days | 70.2 days | 69.1 days | 38.8 days |
| FY2025 | 43.2 days | 70.2 days | 71.3 days | 42.1 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -3.8 percent |
| FY2020 | -6.8 percent |
| FY2021 | -1.8 percent |
| FY2022 | 0.4 percent |
| FY2023 | -4.9 percent |
| FY2024 | -2.0 percent |
| FY2025 | -3.4 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-20 | Boyce Marlena K. SVP - CHRO | Grant | 6,220 | $0.00 | — |
| 2026-10-20 | Meisenzahl Benjamin E. SVP - Finance and CFO | Grant | 13,805 | $0.00 | — |
| 2026-10-20 | Lang James P. SVP - Enterprise Finance & CAO | Grant | 2,335 | $0.00 | — |
| 2026-10-20 | Davie Colin M. Pres. & GM, Glob. Supply Chain | Grant | 7,000 | $0.00 | — |
| 2026-10-20 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Grant |
| 12,055 |
| $0.00 |
| — |
| 2026-10-20 | Rea Todd D President, Consumer Brands Grp | Grant | 4,470 | $0.00 | — |
| 2026-10-20 | Young Bryan J SVP - Corp Strategy & Devel. | Grant | 3,500 | $0.00 | — |
| 2026-10-20 | Binns Justin T President, Glob. Architectural | Grant | 12,055 | $0.00 | — |
| 2026-10-20 | Petz Heidi G President & CEO | Grant | 47,640 | $0.00 | — |
| 2026-10-20 | Jaye James R SVP - IR & Corp. Comm. | Grant | 2,335 | $0.00 | — |
| 2026-10-20 | Garceau Mary L SVP - CLO and Secretary | Grant | 7,585 | $0.00 | — |
| 2026-10-02 | Anderson Kerrii B Director | Grantindirect | 31 | $324.14 | $10k |
| 2026-10-02 | Thaman Michael H Director | Grantindirect | 104 | $324.14 | $34k |
| 2026-10-02 | Williams Thomas Director | Grantindirect | 104 | $324.14 | $34k |
| 2026-10-02 | Gamgort Robert James Director | Grantindirect | 104 | $324.14 | $34k |
| 2026-08-18 | 4 co-filers President, Glob. Architectural | Gift | 813 | $0.00 | $0 |
| 2026-08-17 | 4 co-filers President, Glob. Architectural | Option exercise | 13,500 | $90.04 | $1.2m |
| 2026-08-17 | 4 co-filers President, Glob. Architectural | Exercise & sell | 13,500 | $352.70 | $4.8m |
| 2026-08-17 | 4 co-filers President, Glob. Architectural | Option exercise | 13,500 | $0.00 | — |
| 2026-08-07 | 3 co-filers President, Glob. Industrial | Option exercise | 90 | $127.98 | $12k |
| 2026-08-07 | 3 co-filers President, Glob. Industrial | Exercise & sell | 7,886 | $368.30 | $2.9m |
| 2026-08-07 | 3 co-filers President, Glob. Industrial | Option exercise | 90 | $0.00 | — |
| 2026-07-06 | Gamgort Robert James Director | Grantindirect | 96 | $350.40 | $34k |
| 2026-07-06 | Williams Thomas Director | Grantindirect | 96 | $350.40 | $34k |
| 2026-07-06 | Thaman Michael H Director | Grantindirect | 96 | $350.40 | $34k |
| 2026-07-06 | Anderson Kerrii B Director | Grantindirect | 29 | $350.40 | $10k |
| 2026-04-06 | Gamgort Robert James Director | Grantindirect | 107 | $315.50 | $34k |
| 2026-04-06 | Williams Thomas Director | Grantindirect | 107 | $315.50 | $34k |
| 2026-04-06 | Thaman Michael H Director | Grantindirect | 107 | $315.50 | $34k |
| 2026-04-06 | Anderson Kerrii B Director | Grantindirect | 32 | $315.50 | $10k |
| 2026-02-24 | Young Bryan J SVP - Corp Strategy & Devel. | Open-market sale | 2,513 | $364.47 | $916k |
| 2026-02-17 | 2 co-filers President & CEO | Grant | 16,800 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers SVP - Finance and CFO | Grant | 960 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers SVP - CHRO | Grant | 1,338 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers SVP - Enterprise Finance & CAO | Grant | 714 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers Pres. & GM, Glob. Supply Chain | Grant | 3,300 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers President, Glob. Industrial | Grant | 9,600 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers President, Consumer Brands Grp | Grant | 5,100 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers SVP - Corp Strategy & Devel. | Grant | 3,900 | $0.00 | $0 |
| 2026-02-17 | 2 co-filers President, Glob. Architectural | Grant | 9,900 | $0.00 | $0 |